human-immunodeficiency-virus-hiv

Documents about human-immunodeficiency-virus-hiv

• 3BNC117-LS and 10-1074-LS in Viremic HIV-infected Individuals#880482ClinicalTrials.gov
• Effects of Doravirine (MK-1439) on Methadone Pharmacokinetics in Methadone-Maintained Participants (MK-1439-045)#914424ClinicalTrials.gov
• A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes#879985ClinicalTrials.gov
• Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission#915731ClinicalTrials.gov
• Safety, Tolerability and Immunogenicity Study of Different Vaccine Schedules With Ad26.Mos.HIV and Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Adults#369880ClinicalTrials.gov
• AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV#868132ClinicalTrials.gov
• Incidence and Prevalence of Cancer in People Living With HIV/AIDS at Cancer Centers in Latin America#911445ClinicalTrials.gov
• Tripterygium Wilfordii Hook F (TwHF) Treatment for Immune Non-responders With HIV-1 Infection#968178ClinicalTrials.gov
• Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen#892040ClinicalTrials.gov
• Effectiveness of Booster With 1 or 2 Doses of HAV Vaccine Among HIV-infected Patients#180220ClinicalTrials.gov
• A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily#902166ClinicalTrials.gov
• Unrealised obligations : implementing HIV and AIDS policy in a large international development organisation#260767University of Pretoria Repository
• Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected Patients#838842ClinicalTrials.gov
• A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-Risk Populations in Kenya, Africa#903050ClinicalTrials.gov
• Meningkatkan Respon Psikologis Tenaga Kerja Indonesia yang Terinfeksi HIV Melalui Dukungan Keluarga dan Peer Group Support#1004805Jurnal Ners
• HIV Medication Adherence in Underserved Populations#899206ClinicalTrials.gov
• IDEAS for Hope to Reduce Suicide Risk and Improve HIV Care Engagement in Tanzania#845429ClinicalTrials.gov
• Integrating Project YES! With WHO-Endorsed Mental Health Approaches Among Youth Living With HIV#916642ClinicalTrials.gov
• Using Social Media to Improve ART Retention and Treatment Outcomes Among YLHIV in Nigeria#827251ClinicalTrials.gov
• Safety and Pharmacokinetics of Oral Islatravir (MK-8591) Once Monthly in Participants at Low Risk of Human Immunodeficiency Virus 1 (HIV-1) Infection (MK-8591-016)#834363ClinicalTrials.gov
• Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal.#845423ClinicalTrials.gov
• Community Home-based Care Intervention and Its Health Outcome in HIV-positive People#898156ClinicalTrials.gov
• Safety, Tolerability and Immunogenicity Study of Different Vaccine Regimens of Trivalent Ad26.Mos.HIV or Tetravalent Ad26.Mos4.HIV Along With Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Adults#377269ClinicalTrials.gov
• A Phase I Multicenter, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of Recombinant Vaccinia Virus Expressing the Envelope Glycoproteins of Human Immunodeficiency Virus#238201ClinicalTrials.gov
• Probiotics in the Management of Necrotizing Enterocolitis in HIV-exposed Premature Infants#832643ClinicalTrials.gov
• A Drug Interaction Study Evaluating Plasma GSK2248761 and GSK1349572 Pharmacokinetics in Healthy Adult Subjects.#851403ClinicalTrials.gov
• Efficacy Study of Different Laboratory Management Strategies and Drug Regimens in HIV-infected Children in Africa#879024ClinicalTrials.gov
• Targeting Non-virally Suppressed Adults With Alcohol Use Disorder in HIV Primary Care#968060ClinicalTrials.gov
• Severe pneumonia in HIV-infected and exposed infants in a paediatric ICU#339281University of Pretoria Repository
• Intervention to Reduce HIV Related Stigma Among Pregnant and Postpartum Women#969121ClinicalTrials.gov
• A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients#804121ClinicalTrials.gov
• Community-based Treatment of Chronic Hepatitis C Monoinfection and Coinfection With HIV in the District of Columbia#837993ClinicalTrials.gov
• Usability Study of IeHS in Indonesia#855823ClinicalTrials.gov
• Body image in children and adolescents diagnosed with the human immunodeficiency virus: a systematic review#947916Repositorio de Universidad Autónoma de Chile.
• A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant Women#862998ClinicalTrials.gov
• Data Science and Qualitative Research for Decision Support in the HIV Care Cascade#882918ClinicalTrials.gov
• Feasibility Study Comparing One vs Two Probes for TA Among Cervical Cancer Screen Positive WLWH in C1001P-CS5 Rwanda#980410ClinicalTrials.gov
• Characterization of CD8 T cell immune responses directed against cytomegalovirus in people living with human immunodeficiency virus (HIV)#142647HAL (France)
• Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART.#831707ClinicalTrials.gov
• Dose Ranging, Switch Study of Islatravir (MK-8591) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]#860581ClinicalTrials.gov
• A Study of Doravirine/Islatravir (DOR/ISL, MK-8591A) for the Treatment of Human Immunodeficiency Virus 1 (HIV-1) Infection in Participants Who Previously Received DOR/ISL (MK-8591A-054)#900726ClinicalTrials.gov
• Pre-exposure Prophylaxis (PrEP) for Health#902941ClinicalTrials.gov
• A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules#143654ClinicalTrials.gov
• RH and Adolescents#829380ClinicalTrials.gov
• A Single Dose of Pembrolizumab in HIV-Infected People#893438ClinicalTrials.gov
• The impact of cytokine levels in young South African children with and without HIV-associated acute lower respiratory infections#385879University of Pretoria Repository
• A Multi-Center Clinical Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS Post First Episode PCP#969174ClinicalTrials.gov
• Study of Niacin on Endothelial Function in HIV-infected Subjects With Low High Density Lipoprotein Cholesterol Levels#879662ClinicalTrials.gov
• Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)#881310ClinicalTrials.gov
• Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects.#883973ClinicalTrials.gov